Real-world efficacy of first-line immunochemotherapy combined with thoracic radiotherapy in elderly patients with extensive-stage small cell lung cancer: a single-center retrospective study

Key Points

• The study aims to evaluate the effectiveness of first-line immunochemotherapy combined with thoracic radiotherapy in elderly patients with extensive-stage small cell lung cancer.
• Conducted as a single-center retrospective analysis
• Included elderly patients diagnosed with extensive-stage small cell lung cancer
• Evaluated treatment efficacy and safety of integrated strategies
• First-line immunochemotherapy combined with thoracic radiotherapy shows a survival benefit in elderly patients
• Consolidative thoracic radiotherapy is associated with favorable survival outcomes
• The safety profile of combined treatment is acceptable